Pretreatment Metabolic Tumor Volume As A Prognostic Factor In HPV‐associated Oropharyngeal Cancer In The Context Of AJCC 8th Edition Staging
John M Floberg, Todd A DeWees, Re-I Chin, Adam A. Garsa, Farrokh Dehdashti, Brian Nussenbaum, Peter J. Oppelt, Douglas R. Adkins, Hiram A. Gay, W. L. Thorstad
Published 2018 · Medicine
Download PDFAnalyze on Scholarcy
BACKGROUND This study evaluates the prognostic significance of 18 F-fluorodeoxyglucose-positron emission tomography ([F-18]FDG-PET)-derived metabolic tumor volume (MTV) in human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinomas (OPSCCs) in the context of AJCC 8th edition staging. METHODS We performed a retrospective study of HPV-associated OPSCCs treated with postoperative or definitive radiation. The prognostic significance of pretreatment MTV for freedom from recurrence (FFR), freedom from distant metastasis (FFDM), and overall survival (OS) was determined using Kaplan-Meier analysis. Multivariate analysis (MVA) was performed using Cox regression. RESULTS In this 153-patient cohort, stratifying by the optimum MTV (24 cm3 ) was prognostic for FFR (P = .0002), FFDM (P = .001), and OS (P < .0001). Metabolic tumor volume (MTV) was prognostic of FFR in AJCC 8th edition stage I/II (P = .03), and stage III patients (P = .04). On multivariate analysis only MTV was a significant factor for OS. CONCLUSION Metabolic tumor volume (MTV) is a significant prognostic factor in HPV-associated OPSCCs, independent of AJCC 8th edition stage.
This paper references
Quang Hong Vuong (1989)
Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.
Chad Tang (2011)
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
B O'Sullivan (2016)
Metabolic tumour volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgery
Han Zhang (2014)
Comparison of unilateral versus bilateral intensity‐modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil
R. Chin (2017)
Likelihood Ratio Tests for Model Selection and Non-Nested Hypotheses
Quang Hieu Vuong (1989)
Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristics.
Michael R. Folkert (2017)
18F-FDG PET/CT Metabolic Tumor Volume and Total Lesion Glycolysis Predict Outcome in Oropharyngeal Squamous Cell Carcinoma
Remy Lim (2012)
Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
Bhishamjit S. Chera (2015)
Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
Shao Hui Huang (2015)
p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status.
James S. Lewis (2010)
Correlation between metabolic tumor volume and pathologic tumor volume in squamous cell carcinoma of the oral cavity.
James D Murphy (2011)
Prognostic value of FDG-PET volumetric parameters in patients with p16-positive oropharyngeal squamous cell carcinoma who received curative resection followed by postoperative radiotherapy or chemoradiotherapy.
Kyung Hwan Kim (2016)
A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen.
Serge J. Smeets (2007)
Textural Features of Pretreatment 18F-FDG PET/CT Images: Prognostic Significance in Patients with Advanced T-Stage Oropharyngeal Squamous Cell Carcinoma
Nai-Ming Cheng (2013)
Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma
Adam A. Garsa (2012)
Prognostic Value of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated by Surgery
Kyu-Ho Choi (2011)
Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522.
David L. Schwartz (2015)
Reevaluation of postoperative radiation dose in the management of human papillomavirus-positive oropharyngeal cancer.
Re-I Chin (2016)
Pathologically determined tumor volume vs pathologic T stage in the prediction of outcome after surgical treatment of oropharyngeal squamous cell carcinoma.
Iain J Nixon (2013)
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
Trang H. La (2008)
Human Papillomavirus and Oropharyngeal Cancer.
Takako Imai Tanaka (2018)
Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.
Phuc Felix Nguyen-Tan (2014)
Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
B O'Sullivan (2013)
FDG-PET/CT as prognostic factor and surveillance tool for postoperative radiation recurrence in locally advanced head and neck cancer
Giwon Kim (2011)
Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study.
I. Frank Ciernik (2003)
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Ronald Boellaard (2014)
Human Papillomavirus and Oropharyngeal Cancer Stage.
Maura L. Gillison (2016)
Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis in Head and Neck Cancer: A Systematic Review and Meta-Analysis
Kyoungjune Pak (2014)
Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation.
B O'Sullivan (2012)
18F-FDG Metabolic Tumor Volume and Total Glycolytic Activity of Oral Cavity and Oropharyngeal Squamous Cell Cancer: Adding Value to Clinical Staging
Elizabeth H Dibble (2012)
Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy
Robert Jeraj (2015)
Tumor volume as a predictor of survival in human papillomavirus-positive oropharyngeal cancer.
Kara S. Davis (2016)
An application of changepoint methods in studying the effect of age on survival in breast cancer
Cécile Parent Contal (1999)
HPV-Mediated (p16+) Oropharyngeal Cancer
B O'Sullivan (2017)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
James A. Stockman (2012)
Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories.
Kristina R Dahlstrom (2016)
This paper is referenced by
The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status.
Jon M Moan (2019)
PET in the Diagnosis of Head and Neck Cancer
Tetsuro Sekine (2020)
Diagnostic Imaging in Head and Neck Cancer
Hiroya Ojiri (2020)